368 related articles for article (PubMed ID: 33430801)
1. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
3. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
[TBL] [Abstract][Full Text] [Related]
4. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
5. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
6.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
Jia Y; Ding X; Zhou L; Zhang L; Yang X
Oncogene; 2021 Jan; 40(2):246-261. PubMed ID: 33122828
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
10. miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer.
Zhang L; Xu J; Yang G; Li H; Guo X
Oncol Res; 2018 Jul; 26(6):949-957. PubMed ID: 29298735
[TBL] [Abstract][Full Text] [Related]
11. A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer.
Gong P; Xu R; Zhuang Q; He X
Biomed Pharmacother; 2020 Jun; 126():110059. PubMed ID: 32208321
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
13. Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
Yang D; Qian H; Fang Z; Xu A; Zhao S; Liu B; Li D
Cancer Med; 2020 Jan; 9(2):700-710. PubMed ID: 31758655
[TBL] [Abstract][Full Text] [Related]
14. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
15. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
16. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
17. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
19. miR-211-5p is down-regulated and a prognostic marker in bladder cancer.
Wang W; Liu Z; Zhang X; Liu J; Gui J; Cui M; Li Y
J Gene Med; 2020 Dec; 22(12):e3270. PubMed ID: 32893379
[TBL] [Abstract][Full Text] [Related]
20. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
